EBS Emergent Biosolutions Inc

USD 10.89 -1.08 ( -9.02)%
Icon

Emergent Biosolutions Inc (EBS) Stock Analysis and Price Targets

COMMON STOCK | Drug Manufacturers - Specialty & Generic | NYE
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Very Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Hold

Average User
Rating

USD 10.89

-1.08 (-9.02)%

N/A

1.99M

USD 12.00(+10.19%)

USD 13.00 (+19.38%)

Icon

EBS

Emergent Biosolutions Inc (USD)
COMMON STOCK | NYE
USD 10.89
-1.08 ( -9.02)%
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Very Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Hold

Average User
Rating

N/A

USD 13.00 (+19.38%)

USD 10.89

Emergent Biosolutions Inc (EBS) Stock Forecast

USD 12.00
(+10.19%)

Based on the Emergent Biosolutions Inc stock forecast from 2 analysts, the average analyst target price for Emergent Biosolutions Inc is USD 12.00 over the next 12 months. Emergent Biosolutions Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Emergent Biosolutions Inc is Very Bearish, which is based on 0 positive signals and 4 negative signals. At the last closing, Emergent Biosolutions Inc’s stock price was USD 10.89. Emergent Biosolutions Inc’s stock price has changed by +21.54% over the past week, +24.46% over the past month and +498.35% over the last year.

No recent analyst target price found for Emergent Biosolutions Inc
No recent average analyst rating found for Emergent Biosolutions Inc

Company Overview Emergent Biosolutions Inc

N/A

N/A

N/A

N/A

USD

USA

Adjusted Closing Price for Emergent Biosolutions Inc (EBS)

Loading...

Unadjusted Closing Price for Emergent Biosolutions Inc (EBS)

Loading...

Share Trading Volume for Emergent Biosolutions Inc Shares

Loading...

Compare Performance of Emergent Biosolutions Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for EBS

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Emergent Biosolutions Inc (Sector: Drug Manufacturers - Specialty & Generic )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
ZTS
Zoetis Inc -2.19 (-1.24%) USD79.77B 33.24 22.42

Frequently Asked Questions About Emergent Biosolutions Inc (EBS) Stock

Based on ratings from 2 analysts Emergent Biosolutions Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Very Bearish. The stock has 4 buy, sell and hold ratings.

Unfortunately we do not have enough data on EBS's stock to indicate if its a good dividend stock.

Based on targets from 2 analysts, the average taret price for EBS is USD 12.00 over the next 12 months. The maximum analyst target price is USD 16 while the minimum anlayst target price is USD 8.

Unfortunately we do not have enough data on EBS's stock to indicate if its overvalued.

The last closing price of EBS's stock was USD 10.89.

Unfortunately we do not currently have any market capitalization data for EBS's stock.

Based on targets from 2 analysts, the average taret price for EBS is projected at USD 12.00 over the next 12 months. This means that EBS's stock price may go up by +10.19% over the next 12 months.

We can't find any ETFs which contains Emergent Biosolutions Inc's stock.

Sorry, we do not have any data on the number of employees for Emergent Biosolutions Inc.

Sorry we do not have any infomation available on Emergent Biosolutions Inc's address.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Frequently Asked Questions About Emergent Biosolutions Inc (EBS) Stock

Based on ratings from 2 analysts Emergent Biosolutions Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Very Bearish. The stock has 4 buy, sell and hold ratings.

Unfortunately we do not have enough data on EBS's stock to indicate if its a good dividend stock.

Based on targets from 2 analysts, the average taret price for EBS is USD 12.00 over the next 12 months. The maximum analyst target price is USD 16 while the minimum anlayst target price is USD 8.

Unfortunately we do not have enough data on EBS's stock to indicate if its overvalued.

The last closing price of EBS's stock was USD 10.89.

Unfortunately we do not currently have any market capitalization data for EBS's stock.

Based on targets from 2 analysts, the average taret price for EBS is projected at USD 12.00 over the next 12 months. This means that EBS's stock price may go up by +10.19% over the next 12 months.

We can't find any ETFs which contains Emergent Biosolutions Inc's stock.

Sorry, we do not have any data on the number of employees for Emergent Biosolutions Inc.

Sorry we do not have any infomation available on Emergent Biosolutions Inc's address.
Loading...